Charts suggest InMode stock is worth buying into weakness, says Jim Cramer

Charts suggest InMode stock is worth buying into weakness, says Jim Cramer

CNBC’s Mad Money host Jim Cramer and Bob Lang review four growth stocks, including shares of medical technology company InMode.

Read the full article here.